Shortage status and enforcement timeline: The reason compounded GLP-1 medications became widely available through telehealth platforms was that both semaglutide and tirzepatide were on the FDA's drug shortage list - semaglutide since March 2022 and tirzepatide since December 2022
Carrying a medical alert card or medical alert bracelet that details any allergies will help to ensure appropriate treatment, as the person may not be able to communicate this themselves in an emergency
A primary issue cited in these cases is Paragard IUD failure, particularly when the device fractures during removal, leaving broken pieces embedded in the uterus
References Coskun, T., Sloop, K.W., Loghin, C., Alsina-Fernandez, J., Urva, S., Bokvist, K.B., Cui, X., Briere, D.A., Cabrera, O., Roell, W.C., Kuchibhotla, U., Moyers, J.S., Benson, C.T., Gimeno, R.E., DAlessio, D.A., & Haupt, A